Late Stage Development

 

Innovative tools like the fully validated AMS   BYOD-type Patient Reported Outcome solution (AMS  ePro) will help to save money and time, e.g. with Patient Diaries and Quality of Life Questionnaires.

AMS  has extensive experience in Late-phase studies (Phases IIIb and IV) and is prepared for the quite new concept of low-interventional studies. The challenge of high-quality data while meeting all requirements, tight timelines and a limited budget, remains in Non-interventional studies (NIS).

In a non-interventional study, you may want to evaluate a real-life patient population and include a large number of investigators and institutions – AMS  processes ensure a smooth handling of all study activities.

Although your project plan is easy, compliance may be problematic. AMS  staff are aware of regulatory and data protection requirements and assure compliance during the course of your study.

 

Read more or find out how AMS  Clinical Research services can meet your needs:

Get in touch with us at:

• 2011 – AMS AMNOG Services pioneer • 2013 – AMS-Investigator SELF-TRAINING PORTAL • 2013 – “BEST CRO” by one of the world’s Top 5 Pharma companies’ CRO Evaluation for AMS – Clinical Operations Services • 2014 – AMS performs Medical App Studies including eCRF-data integration • 2015 – AMS Medical Science is awarded “Provider of the Year, worldwide” by one of the world’s Top 10 Pharma companies • 2015 – AMS develops an E-feasibility tool • 2015 – Innovative Tool for Patient Reported Outcomes: AMS ePro (BYOD-type PRO solution) is developed • 2016 – AMS – Regulatory Affairs is nominated on the short-list for TOPRA Award for Regulatory Excellence

Meet us at a conference

News

  • EMA-EUnetHTA Parallel Consultation

    Artikel vom 01 August 2017 News

    Profit from the simultaneous feedback of regulatory and HTA bodies in order to generate your data set in the most efficient way! What is new? EMA and EUnetHTA h... weiterlesen
  • AbbVie TRIUMPH AWARD 2015

    Artikel vom 24 Juni 2016 News

    Um Kooperationen auszuzeichnen und Partner entsprechend zu honorieren, verleiht AbbVie Global jährlich den Preis 'Supplier of the Year'. Kriterien, um für den P... weiterlesen
  • AMS ePRO

    Artikel vom 01 Juni 2016 News

    The aim of the AMS -ePRO system is to enable patients to enter online (on their own smartphones, tablets or computers) their health related data in response to... weiterlesen